Stay informed with the latest developments in mRNA science and manufacturing. Find updates on mRNA technology advancements, regulatory milestones, industry trends, and company announcements.
BASE scientists have developed a method, published in Nature Communications, using nanopore sequencing to analyse the quality of mRNA vaccines. This approach enables real-time analysis of mRNA molecules at single-molecule resolution.
The Queensland Government, Sanofi, Griffith University, and The University of Queensland announced the establishment of the Sanofi Translational Science Hub (TSH) to position Queensland as a global leader in mRNA technologies. Supported with $280 million in funding, the TSH will strengthen mRNA research, clinical trials, and workforce training in Queensland.
The Australian Government supported the establishment of BASE, a pilot facility for producing mRNA vaccines and therapies for research purposes. Supported by The University of Queensland and Therapeutic Innovation Australia, the BASE facility provides scientists across Australia with access to advanced mRNA technologies.
Our team is available to help with your mRNA projects.